• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

Slides for the September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee

 

Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance
 
 
Morning Session
 
FDA
 
FDA Slides, Lixivaptan, for the September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee (PDF – 399KB)
 
 
Cardiokine Biopharma, LLC
 
 Cardiokine Slides, Lixivaptan, for the September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee (PDF – 5.34MB)
 
 
Afternoon Session
 
FDA
  
FDA Slides, Phenylephrine Hydrochloride Injection, for the September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee (PDF – 688KB)
 
 
West-Ward Pharmaceutical Corp.
 
 West-Ward Slides, Phenylephrine Hydrochloride Injection, for the September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee (PDF – 651KB)